ApoM may play an important role in HDL-mediated cholesterol reverse transport and is an attractive target for the treatment of diabetes, obesity, hyperinsulinemia and dyslipidemia [1, 2]. Here, APOM is linked to obesity due to melanocortin 4 receptor deficiency.